Seasonal Influenza Vaccines Market Forecast

Seasonal Influenza Vaccines Market Forecast published by Datamonitor in August, 2009. This report price starts from US $ 15200.

Introduction

Abstract

Introduction

Fuelled by the pandemic flu threat, the influenza market has expanded rapidly in recent years. This growing commercial opportunity has encouraged companies to develop new technologies and increase manufacturing capacity for influenza vaccines and antivirals. The H1N1 pandemic will stimulate further growth, but also confronts industry and public health stakeholders with new challenges.

Key reasons to purchase this research

• Review the clinical and commercial factors driving new product decisions in influenza vaccines and the strategies of key players in the market
• Size the market with patient-based scenario forecasts of the seasonal vaccines market and a thorough analysis of the vaccine and antiviral pipeline
• Understand concerns, unmet needs and future opportunities in influenza prevention and therapy

Table of Contents

OVERVIEW

• This product contains forecasts for seasonal influenza vaccines across the seven major markets from the influenza season 2009/10 to 2018/19. It has been designed for delivery in an excel data pack format, but for more detail about this disease area please see the accompanying Commercial Insight: Influenza Vaccines and Antivirals word document and PowerPoint executive presentation (DMHC2516).
  • The associated report and PowerPoint presentation can be found under Latest research in the Knowledge centre, through the search function or by contacting your sales representative.
  • Please select the data pack option from the download menu at the side of the page to access the model.
  • Introduction
  • Scope of this research
  • Research and analysis highlights
  • Key reasons to read this report
• Forecasting Methodology
  • The forecasting model:

FIGURES

• Figure: Datamonitor' s patient-based vaccine forecasting model - influence factors

Related Reports